Medtronic Defeats Suit Over Allegedly Flawed Cardiac Device

Medtronic Inc. won dismissal of a man’s suit alleging injury from an allegedly defective implantable cardiac defibrillator lead, as a Louisiana federal court said he failed to plead a non-preempted product liability claim.

But Matthew Naquin may be able to assert a viable breach-of-contract claim against the medical device company, the U.S. District Court for the Eastern District of Louisiana said Wednesday, allowing him another chance to plead that small part of the suit.

Naquin underwent surgery in March 2016, receiving a Medtronic Evera XT VR Implantable Cardiac Defribrillator. The ICD included an allegedly defective Sprint Quattro lead that Naquin ...